“Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review”. The Review of Diabetic Studies (February 10, 2025): 1039–1048. Accessed February 10, 2026. https://www.diabeticstudies.org/index.php/RDS/article/view/1715.